The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Share News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.10
Bid: 34.70
Ask: 35.15
Change: -1.70 (-4.62%)
Spread: 0.45 (1.297%)
Open: 36.70
High: 36.70
Low: 34.45
Prev. Close: 36.80
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Jefferies raises Spirax-Sarco; cuts Victrex

Wed, 31st Jan 2024 09:21

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

----------

FTSE 100

----------

Jefferies raises Spirax-Sarco Engineering to 'hold' (underperform) - price target 9,740 (7,775) pence

----------

Jefferies cuts Diageo price target to 2,900 (3,000) pence - 'hold'

----------

JPMorgan cuts Diageo price target to 3,200 (3,500) pence - 'neutral'

----------

Barclays cuts Diageo price target to 3,550 (3,730) pence - 'overweight'

----------

Deutsche Bank cuts Diageo price target to 2,400 (2,450) pence - 'sell'

----------

UBS cuts Diageo price target to 2,600 (2,650) pence - 'sell'

----------

Bernstein cuts Diageo price target to 3,440 (3,580) pence - 'outperform'

----------

Jefferies raises Aviva price target to 490 (480) pence - 'buy'

----------

JPMorgan raises WPP price target to 890 (850) pence - 'neutral'

----------

UBS raises WPP price target to 725 (700) pence - 'sell'

----------

Deutsche Bank cuts Vodafone price target to 145 (165) pence - 'buy'

----------

Goldman Sachs cuts SSE price target to 2,348 (2,430) pence - 'buy'

----------

Deutsche Bank raises London Stock Exchange target to 8,300 (8,100) pence - 'hold'

----------

FTSE 250

----------

Goldman Sachs cuts Ithaca Energy price target to 190 (227) pence - 'buy'

----------

Jefferies cuts Morgan Advanced Materials to 'hold' (buy) - price target 315 (400) pence

----------

Jefferies cuts Victrex to 'underperform' (hold) - price target 1,190 (1,420) pence

----------

Jefferies raises Elementis to 'buy' (hold) - price target 170 (110) pence

----------

Goldman Sachs cuts Harbour Energy to 'sell' (buy) - price target 260 (300) pence

----------

SMALL CAP

----------

Berenberg cuts Resolute Mining price target to 26 (28) pence - 'buy'

----------

Berenberg raises Ecora Resources price target to 160 (150) pence - 'buy'

----------

RBC cuts Ecora Resources price target to 130 (140) pence - 'outperform'

----------

RBC cuts Alliance Pharma price target to 60 (65) pence - 'outperform'

----------

Jefferies cuts AB Dynamics to 'underperform' (hold) - price target 1,500 (1,220) pence

----------

Jefferies raises XP Power to 'buy' (hold) - price target 1,640 (2,210) pence

----------

Jefferies raises Team17 price target to 230 (180) pence - 'hold'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
31 Mar 2016 15:15

Earnings, Trading Statements Calendar - Week Ahead

Read more
21 Jan 2016 09:15

Alliance Pharma Will Meet Expectations For 2015 As Revenue Rises

Read more
26 Nov 2015 10:24

WINNERS & LOSERS SUMMARY: BHP Hit By Downgrade, Brazil Accusation

Read more
26 Nov 2015 08:04

Sinclair IS Selling Non-Aesthetics Business To Alliance Pharma (ALLISS)

Read more
5 Nov 2015 09:46

Alliance Pharma Reaches GBP6.7 Million ImmuCyst Settlement With Sanofi

Read more
9 Sep 2015 08:39

BROKER RATINGS SUMMARY: Numis Upgrades Hargreaves Lansdown To Add

Read more
9 Sep 2015 07:57

Alliance Pharma To Meet Full-Year Market Expectations As Profit Rises

Read more
16 Jul 2015 08:15

Sphere Medical Hires Ex-Alliance Pharma Finance Chief As CFO

Read more
13 Jul 2015 16:21

Alliance Pharma trading in line; confident on full-year outlook

(ShareCast News) - Speciality pharmaceutical company Alliance Pharma said it was trading in line with expectations, with sales of around £22.8m in in the six months ended June 30, up from £21.4m in the same period last year. In a trading update ahead of its interim results, the company said its grow

Read more
13 Jul 2015 07:59

Alliance Pharma Trading In Line With Hydromol Performing Well

Read more
10 Jul 2015 10:27

Alliance Pharma appoints Andrew Franklin as finance director

Specialty pharmaceutical company Alliance Pharma announced the appointment of Andrew Franklin as finance director with effect from 28 September 2015. Franklin joins the company from Panasonic Europe, where he was general manager, European tax and accounting. Before that, he was finance director and

Read more
10 Jul 2015 06:55

Alliance Pharma Appoints Andrew Franklin As Finance Director

Read more
26 Jun 2015 13:16

DIRECTOR DEALINGS SUMMARY: Indus Gas CEO Ups Interest To 82.66%

Read more
23 Jun 2015 12:59

DIRECTOR DEALINGS: Alliance Pharma Non-Executive Sells Shares

Read more
19 Jun 2015 13:02

DIRECTOR DEALINGS SUMMARY: Patisserie Chairman, CEO And CFO Sell

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.